Navigation Links
Neogen Launches Quickest Test Available for Tetracyclines in Milk
Date:2/13/2008

LANSING, Mich., Feb. 13 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has expanded its line of products developed for the dairy industry to include the quickest test available for tetracycline residues in milk. The tetracyclines group of dairy antibiotics is used to treat bovine mastitis, and includes tetracycline, chlortetracycline, and oxytetracycline.

Neogen's new TetraStar(R) dairy antibiotic test for tetracyclines complements the company's widely used BetaStar(R) test for the beta-lactam group of dairy antibiotics, which includes amoxicillin, ampicillin, cephapirin, cloxacillin, and penicillin. TetraStar produces clear results in a market-best six minutes, and like BetaStar, is an extremely simple dipstick test that requires only minimal training and equipment to produce consistently accurate results.

"As tetracyclines have emerged as a second choice of antibiotics to beta- lactams for the management of mastitis in dairy herds in certain regions of the world, the concern over tetracycline drug residues in milk has grown," said Lon Bohannon, Neogen's president. "Developing TetraStar allows us to offer the worldwide dairy industry yet another simple solution to protect its consumers and businesses. Two years ago when we acquired the dairy antibiotics business from UCB, including its popular BetaStar line, we did so with the idea of expanding the business by introducing new products based on market demand. Launching TetraStar today is yet another example of our commitment to supply innovative products to help meet our customers' needs."

Because the tetracyclines group of dairy antibiotics is not yet used as universally as the beta-lactam group, regulations governing the maximum allowable levels of tetracyclines in milk are not as widespread. As the European Union has set a maximum residue level of 100 parts per billion for tetracyclines in milk, Neogen expects the strongest initial interest for its TetraStar product from EU countries, and especially Spain, where tetracyclines are more widely used.

The worldwide market for antibiotic testing of milk has been estimated to exceed $60 million. A significant portion of that total market is in the United States, where virtually every load of raw milk delivered to dairy processing plants is tested for antibiotic residues.

In addition to its growing line of dairy antibiotic tests, Neogen's Food Safety Division also offers the dairy industry: rapid milk allergen tests that allow multipurpose production lines to be tested quickly and reliably following the sanitation process; rapid foodborne pathogen and indicator organism tests to ensure product safety and quality; and an unequaled sanitation monitoring system that puts the speed and convenience of ATP testing in a lightweight, rugged instrument that fits in the palm of one's hand. Neogen's Animal Safety Division also offers the dairy industry a wide variety of offerings, including a comprehensive line of hoof care and obstetrical products.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
2. Neogen Acquires Assets of Rivard Instruments
3. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
4. Neogen Acquires Kane Enterprises
5. Lucid Launches VivaNet(R) Telemedicine Server for Dermatology Applications
6. Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM)
7. Barr Launches Generic Fosamax(R) Tablets, 70 mg
8. NHS Choices Launches New BMI Calculator
9. Oncothyreon launches new corporate website
10. Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program
11. Arryx Launches HOTkit(TM) Complete for Dynamic, Scientific Manipulation of Microscopic Elements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today provided an update on the Company,s cases ... Texas and announcing that those ... Re-examination ("IPR") proceedings that VTech and Uniden filed ... on only certain claims of two of the patents ...
(Date:2/3/2016)... 2016   ViaCyte, Inc ., a leading, ... stem cell-derived islet replacement therapy for the treatment ... announced that ViaCyte and Janssen Biotech, Inc., one ... Johnson, have agreed to consolidate the assets of ... provides ViaCyte with an exclusive license to all ...
(Date:2/3/2016)... , Feb. 3, 2016 New ... more than $1 million for researchers in ... on health-related research that demonstrates exciting potential.   ... of funding for the New Jersey Health Foundation Research ... members at these educational institutions— Princeton University, Rutgers ...
(Date:2/3/2016)... Mass. , Feb. 3, 2016  Silk Therapeutics, Inc., ... financing round. Silk Therapeutics has now raised a total of ... made by the company. The Series A2 round was led ... Massachusetts , with participation from new investors Lear Corporation ... Sheri and Roy P. Disney ; Richard Sackler , ...
Breaking Biology Technology:
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/25/2016)... Pa. , Jan. 25, 2016   Unisys Corporation ... system at John F. Kennedy (JFK) International Airport, New ... Protection (CBP) identify imposters attempting to enter the ... not belong to them. pilot testing of the ... initially at three terminals at JFK during January 2016. --> ...
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
Breaking Biology News(10 mins):